| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |